We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

13 hedge funds and large institutions have $4.1M invested in AIM ImmunoTech in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

7% less funds holding

Funds holding: 14 → 13 (-1)

11% less capital invested

Capital invested by funds: $4.63M → $4.1M (-$530K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$74.6K
2
Morgan Stanley
Morgan Stanley
New York
+$59.7K
3
Renaissance Technologies
Renaissance Technologies
New York
+$59.7K
4
BIT
BlackRock Institutional Trust
California
+$44.8K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$29.8K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$44.8K
2
Citadel Advisors
Citadel Advisors
Florida
-$21K
3
WS
Wedbush Securities
California
-$14.9K
4
Bank of America
Bank of America
North Carolina
-$10K
5
PSC
Piper Sandler & Co
Minnesota
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.29M +$29.8K +2 +2%
BIT
2
BlackRock Institutional Trust
California
$1.27M +$44.8K +3 +3%
OAM
3
Occidental Asset Management
California
$570K – – –
F
4
FutureAdvisor
California
$323K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$224K – – –
VKH
6
Virtu KCG Holdings
New York
$83K +$74.6K +5 +500%
Renaissance Technologies
7
Renaissance Technologies
New York
$64K +$59.7K +4 +400%
Northern Trust
8
Northern Trust
Illinois
$59K – – –
Morgan Stanley
9
Morgan Stanley
New York
$58K +$59.7K +4 New
BTS
10
BB&T Securities
Virginia
$32K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
$31K +$14.9K +1 +100%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$26K -$44.8K -3 -60%
State Street
13
State Street
Massachusetts
$21K – – –
WS
14
Wedbush Securities
California
$19K -$14.9K -1 -50%
GC
15
Guggenheim Capital
Illinois
$8K +$14.9K +1 New
Goldman Sachs
16
Goldman Sachs
New York
$6K – – –
UBS Group
17
UBS Group
Switzerland
$5K – – –
JIC
18
Joel Isaacson & Co
New York
$4K – – –
Wells Fargo
19
Wells Fargo
California
$3K – – –
BA
20
BlackRock Advisors
Delaware
$2K – – –
ICAS
21
Investors Capital Advisory Services
Massachusetts
$2K – – –
CHC
22
City Holding Co
West Virginia
$1K – – –
NPC
23
National Planning Corporation
California
$926 – – –
Bank of America
24
Bank of America
North Carolina
– -$10K -1 Closed
Citadel Advisors
25
Citadel Advisors
Florida
– -$21K -1 Closed
1
2

AIM Hedge Fund Activity: Q4 2014 in Review

13 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2014, worth a combined $4.1M — down 11% from $4.63M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AIM and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.

The largest buyer was Virtu KCG Holdings, adding an estimated $74.6K. The largest seller was Dimensional Fund Advisors, cutting an estimated $44.8K.

  • 13 institutional investors held AIM ImmunoTech (AIM) as of Q4 2014, down from 14 in Q3 2014.
  • Funds reported $4.1M of AIM ImmunoTech stock for Q4 2014, down 11% quarter-over-quarter.
  • 2 funds opened new AIM ImmunoTech positions in Q4 2014 and 3 closed out, a net change of -1 holder.
  • The largest AIM ImmunoTech buyer in Q4 2014 was Virtu KCG Holdings, an estimated $74.6K added.
  • The largest AIM ImmunoTech seller in Q4 2014 was Dimensional Fund Advisors, an estimated $44.8K sold.

Based on aggregated 13F filings for Q4 2014.